CAS Number186826-86-8
SynonymsBAY-12-8039; Moxifloxacinehydrochloride; Moxifloxacin; Moxiflaxacin HCL; Avelox,Avalox; Vigamox; MoxifloxacineHCl; Octegra; Izilox; MOXIFLOXACIN HCL; Moxiflocacin hydrochloride; MFCD00949117; Moxifloxacin hydrochloride; Actira; Moxifloxacin (Hydrochloride); Proflox; Avelox; Avalox
Molecular FormulaC21H25O4N3Cl1F1
Molecular Weight437.9
Purity98%
Boiling Point636.4ºC at 760 mmHg
Appearanceoff-white to yellow powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 186826-86-8 |
| Catalog No. | 2A-9011514 |
| Chinese Name | 盐酸莫西沙星 |
| Synonyms | BAY-12-8039; Moxifloxacinehydrochloride; Moxifloxacin; Moxiflaxacin HCL; Avelox,Avalox; Vigamox; MoxifloxacineHCl; Octegra; Izilox; MOXIFLOXACIN HCL; Moxiflocacin hydrochloride; MFCD00949117; Moxifloxacin hydrochloride; Actira; Moxifloxacin (Hydrochloride); Proflox; Avelox; Avalox |
| Molecular Formula | C21H25O4N3Cl1F1 |
| Molecular Weight | 437.9 |
| Purity | 98 |
| Boiling Point | 636.4ºC at 760 mmHg |
| Appearance | off-white to yellow powder |
| Storage Condition | 2-8°C |
| Inventory | 1kg |
| Application | Moxifloxacin hydrochloride is a fluoroquinolone antibiotic. |
| HTC | 2933499090 |
| MDL Number | MFCD00949117 |
| SMILES | COc1c(N2CC3CCCNC3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl |
| InChI | InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H |
| InChI Key | IDIIJJHBXUESQI-DFIJPDEKSA-N |
| MSDS | msds/11514_1_186826_86_8.pdf |
| Use of | Properties Articles11 Name moxifloxacin hydrochloride Synonym More Synonyms Moxifloxacin HCl Biological Activity Related Catalog Signaling Pathways >> Anti-infection >> Bacterial Research Areas >> Infection References [1]. Balfour, J.A. and H.M. Lamb, Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs, 2000. 59(1): p. 115-39. [2]. Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88. [3]. Ioannidis, O., et al., Effect of moxifloxacin on the survival, lipid peroxidation and inflammation of immunosuppressed rats with soft tissue infection from Stenotrophomonas maltophilia. Microbiol Immunol, 2013. Chemical & Physical Properties Exact Mass 437.151764 PSA 83.80000 LogP 3.56630 InChIKey IDIIJJHBXUESQI-DFIJPDEKSA-N Safety Information Hazard Codes Xi RIDADR NONH for all modes of transport RTECS VB1983750 HS Code 2933499090 Synthetic Route Moxifloxacin CAS#:151096-09-2 Moxifloxacin HCl CAS#:186826-86-8 1-cyclopropyl-6... CAS#:139693-52-0 (S,S)-2,8-Diaza... CAS#:151213-40-0 Moxifloxacin HCl CAS#:186826-86-8 CAS#:496919-99-4 (S,S)-2,8-Diaza... CAS#:151213-40-0 Moxifloxacin HCl CAS#:186826-86-8 Precursor & DownStream Precursor 7 CAS#:151096-09-2 Moxifloxacin CAS#:139693-52-0 1-cyclopropyl-6... CAS#:151213-40-0 (S,S)-2,8-Diaza... CAS#:192927-63-2 Moxifloxacin hy... DownStream 1 CAS#:151096-09-2 Moxifloxacin |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Location | CN-V |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Mirtazapine | 85650-52-8 | 2A-9011463 |
| Moexipril | 103775-10-6 | 2A-9011482 |
| Mometasone furoate | 83919-23-7 | 2A-9011486 |
| Montelukast sodium | 151767-02-1 | 2A-9011498 |
| Morphine N-oxide | 639-46-3 | 2A-9011507 |
| Mycophenolate Mofeil | 2A-302613 | 2A-9011530 |
| Mycophenolate mofetil | 128794-94-5 | 2A-9011531 |
| Nabumetone | 42924-53-8 | 2A-9011542 |
| Nadolol | 42200-33-9 | 2A-9011546 |
| Naloxone hydrochloride | 357-08-4 | 2A-9011566 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS